ATE356612T1 - Orale, pharmazeutische darreichungsformen von flüssigen medikamenten mitverbesserter bioverfügbarkeit - Google Patents
Orale, pharmazeutische darreichungsformen von flüssigen medikamenten mitverbesserter bioverfügbarkeitInfo
- Publication number
- ATE356612T1 ATE356612T1 AT03760660T AT03760660T ATE356612T1 AT E356612 T1 ATE356612 T1 AT E356612T1 AT 03760660 T AT03760660 T AT 03760660T AT 03760660 T AT03760660 T AT 03760660T AT E356612 T1 ATE356612 T1 AT E356612T1
- Authority
- AT
- Austria
- Prior art keywords
- dosage forms
- pharmaceutical dosage
- oral pharmaceutical
- improved bioavailability
- liquid medications
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 2
- 229940079593 drug Drugs 0.000 title abstract 2
- 239000007788 liquid Substances 0.000 title abstract 2
- 239000002552 dosage form Substances 0.000 title 1
- 239000007787 solid Substances 0.000 abstract 2
- 239000004094 surface-active agent Substances 0.000 abstract 2
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000003623 enhancer Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Inorganic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2002MI001392A ITMI20021392A1 (it) | 2002-06-25 | 2002-06-25 | Forme farmaceutiche per la somministrazione orale di farmaci liquidi a temperatura ambiente dotate di migliore biodisponibilita' |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE356612T1 true ATE356612T1 (de) | 2007-04-15 |
Family
ID=11450079
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03760660T ATE356612T1 (de) | 2002-06-25 | 2003-06-20 | Orale, pharmazeutische darreichungsformen von flüssigen medikamenten mitverbesserter bioverfügbarkeit |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US20060171969A1 (https=) |
| EP (1) | EP1526839B1 (https=) |
| JP (1) | JP2005530835A (https=) |
| KR (1) | KR20060076136A (https=) |
| CN (1) | CN1319518C (https=) |
| AT (1) | ATE356612T1 (https=) |
| AU (1) | AU2003246564B2 (https=) |
| CA (1) | CA2491152A1 (https=) |
| DE (1) | DE60312523T2 (https=) |
| DK (1) | DK1526839T3 (https=) |
| ES (1) | ES2285182T3 (https=) |
| HK (1) | HK1080364B (https=) |
| IL (1) | IL165601A0 (https=) |
| IT (1) | ITMI20021392A1 (https=) |
| MX (1) | MXPA04012852A (https=) |
| NO (1) | NO20050347L (https=) |
| NZ (1) | NZ537204A (https=) |
| PL (1) | PL206599B1 (https=) |
| PT (1) | PT1526839E (https=) |
| RU (1) | RU2323003C2 (https=) |
| SI (1) | SI1526839T1 (https=) |
| WO (1) | WO2004000273A1 (https=) |
| ZA (1) | ZA200410109B (https=) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1303671B1 (it) * | 1998-07-28 | 2001-02-23 | Nicox Sa | Sali dell'acido nitrico con farmaci attivi nel trattamento dipatologie del sistema respiratorio |
| US20030148818A1 (en) * | 2002-01-18 | 2003-08-07 | Myrhum Mark C. | Golf club woods with wood club head having a selectable center of gravity and a selectable shaft |
| SE0200895D0 (sv) * | 2002-03-22 | 2002-03-22 | Astrazeneca Ab | New pharmaceutical composition |
| WO2003103602A2 (en) | 2002-06-11 | 2003-12-18 | Nitromed, Inc. | Nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| CA2491127A1 (en) | 2002-07-03 | 2004-01-15 | Nitromed, Inc. | Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| ES2285233T3 (es) | 2002-12-20 | 2007-11-16 | Niconovum Ab | Un material en particulas que contiene nicotina y celulosa microcristalina fisicamente y quimicamente estable. |
| FR2873923B1 (fr) * | 2004-08-05 | 2007-01-12 | Gattefosse Holding Sa | Particule solide anhydre contenant une composition lipidique liquide et composition pharmaceutique contenant lesdites particules |
| WO2006085217A2 (en) * | 2005-02-08 | 2006-08-17 | Pfizer Products Inc. | Solid adsorbates of hydrophobic drugs |
| PL1879466T5 (pl) * | 2005-03-04 | 2016-07-29 | Dsm Ip Assets Bv | Spożywcza cząsteczkowa kompozycja lipidowa |
| US20080260816A1 (en) * | 2005-09-16 | 2008-10-23 | Bengt Herslof | Particulate Lipid Pharmaceutical Composition |
| US20080293781A1 (en) | 2005-11-23 | 2008-11-27 | Alberto Gasco | Salicylic Acid Derivatives |
| EP2786749A1 (en) * | 2006-02-03 | 2014-10-08 | Nicox S.A. | Use of nitrooxyderivative of drug for the treatment of muscular dystrophies |
| US9402809B2 (en) | 2006-03-16 | 2016-08-02 | Niconovum Usa, Inc. | Snuff composition |
| MX2009011493A (es) * | 2007-04-25 | 2009-11-09 | Teva Pharma | Complejo de excipiente farmaceutico. |
| WO2009149053A2 (en) * | 2008-06-02 | 2009-12-10 | Dr. Reddy's Laboratories Ltd. | Naproxcinod process and solid dispersion |
| US9474303B2 (en) | 2011-09-22 | 2016-10-25 | R.J. Reynolds Tobacco Company | Translucent smokeless tobacco product |
| US20130078307A1 (en) | 2011-09-22 | 2013-03-28 | Niconovum Usa, Inc. | Nicotine-containing pharmaceutical composition |
| US9629392B2 (en) | 2011-09-22 | 2017-04-25 | R.J. Reynolds Tobacco Company | Translucent smokeless tobacco product |
| US9084439B2 (en) | 2011-09-22 | 2015-07-21 | R.J. Reynolds Tobacco Company | Translucent smokeless tobacco product |
| US9763928B2 (en) | 2012-02-10 | 2017-09-19 | Niconovum Usa, Inc. | Multi-layer nicotine-containing pharmaceutical composition |
| US9044035B2 (en) | 2012-04-17 | 2015-06-02 | R.J. Reynolds Tobacco Company | Remelted ingestible products |
| ES2821528T3 (es) | 2012-11-14 | 2021-04-26 | Grace W R & Co | Composiciones que contienen un material biológicamente activo y un óxido inorgánico no ordenado |
| CN102964250A (zh) * | 2012-11-19 | 2013-03-13 | 吉林大学 | 氟比洛芬丁香酚酯药用化合物及其制剂和制备方法 |
| US9180104B2 (en) | 2013-03-13 | 2015-11-10 | Tris Pharma, Inc. | Benzonatate modified release solid tablets and capsules |
| CN105188677A (zh) | 2013-03-13 | 2015-12-23 | 特瑞斯制药股份有限公司 | 苯佐那酯调释固体片剂和胶囊剂 |
| EP4072516A1 (en) | 2019-12-09 | 2022-10-19 | Nicoventures Trading Limited | Oral product comprising a cannabinoid |
| US11617744B2 (en) | 2019-12-09 | 2023-04-04 | Nico Ventures Trading Limited | Moist oral compositions |
| US11969502B2 (en) | 2019-12-09 | 2024-04-30 | Nicoventures Trading Limited | Oral products |
| US11793230B2 (en) | 2019-12-09 | 2023-10-24 | Nicoventures Trading Limited | Oral products with improved binding of active ingredients |
| US12433321B2 (en) | 2019-12-09 | 2025-10-07 | Nicoventures Trading Limited | Oral composition with beet material |
| US12310959B2 (en) | 2019-12-09 | 2025-05-27 | Nicoventures Trading Limited | Oral compositions with reduced water content |
| US12439952B2 (en) | 2019-12-09 | 2025-10-14 | Nicoventures Trading Limited | Moist oral compositions |
| US12520867B2 (en) | 2019-12-09 | 2026-01-13 | Nicoventures Trading Limited | Buffered oral compositions |
| US12439949B2 (en) | 2019-12-09 | 2025-10-14 | Nicoventures Trading Limited | Oral compositions with reduced water activity |
| US11826462B2 (en) | 2019-12-09 | 2023-11-28 | Nicoventures Trading Limited | Oral product with sustained flavor release |
| MX2022007085A (es) * | 2019-12-09 | 2022-08-19 | Nicoventures Trading Ltd | Nanoemulsion para uso oral. |
| US11872231B2 (en) | 2019-12-09 | 2024-01-16 | Nicoventures Trading Limited | Moist oral product comprising an active ingredient |
| MX2023015529A (es) | 2021-06-25 | 2024-03-05 | Nicoventures Trading Ltd | Productos orales y metodo de fabricacion. |
| IL312564A (en) | 2021-11-05 | 2024-07-01 | Cinclus Pharma Holding Ab Publ | Polymorphs of the hydrochloride salt of linfarezan glurate |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5266615A (en) * | 1975-11-29 | 1977-06-02 | Sawai Seiyaku Kk | Manufacturing of solidified oily liquid substance |
| JPS56169622A (en) * | 1980-06-03 | 1981-12-26 | Kissei Pharmaceut Co Ltd | Method of making solid preparation from oily substance |
| JPS58213073A (ja) * | 1982-06-07 | 1983-12-10 | Masatoshi Yamada | 油状物質の固形化法 |
| US6054136A (en) * | 1993-09-30 | 2000-04-25 | Gattefosse S.A. | Orally administrable composition capable of providing enhanced bioavailability when ingested |
| US5968542A (en) * | 1995-06-07 | 1999-10-19 | Southern Biosystems, Inc. | High viscosity liquid controlled delivery system as a device |
| BRPI9810945B8 (pt) * | 1997-06-27 | 2021-05-25 | Abraxis Bioscience Inc | formulações de agentes farmacológicos, métodos para sua preparação e métodos para uso das mesmas |
| JP2000016934A (ja) * | 1998-06-30 | 2000-01-18 | Eisai Co Ltd | テプレノンを含有した錠剤 |
| EP2127642A3 (en) * | 1998-08-13 | 2010-02-24 | Cima Labs, Inc. | Microemulsions as solid dosage forms for oral administration |
| EP1140027B1 (en) * | 1998-12-23 | 2005-10-12 | Alza Corporation | Dosage forms comprising porous particles |
| US6294192B1 (en) * | 1999-02-26 | 2001-09-25 | Lipocine, Inc. | Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents |
| IT1311924B1 (it) * | 1999-04-13 | 2002-03-20 | Nicox Sa | Composti farmaceutici. |
| US6793934B1 (en) * | 1999-12-08 | 2004-09-21 | Shire Laboratories, Inc. | Solid oral dosage form |
| SE0000773D0 (sv) * | 2000-03-08 | 2000-03-08 | Astrazeneca Ab | New formulation |
| SE0000774D0 (sv) * | 2000-03-08 | 2000-03-08 | Astrazeneca Ab | New formulation |
| SE0200895D0 (sv) * | 2002-03-22 | 2002-03-22 | Astrazeneca Ab | New pharmaceutical composition |
-
2002
- 2002-06-25 IT IT2002MI001392A patent/ITMI20021392A1/it unknown
-
2003
- 2003-06-20 CN CNB038151812A patent/CN1319518C/zh not_active Expired - Fee Related
- 2003-06-20 CA CA002491152A patent/CA2491152A1/en not_active Abandoned
- 2003-06-20 DE DE60312523T patent/DE60312523T2/de not_active Expired - Lifetime
- 2003-06-20 AU AU2003246564A patent/AU2003246564B2/en not_active Ceased
- 2003-06-20 NZ NZ537204A patent/NZ537204A/en not_active IP Right Cessation
- 2003-06-20 PT PT03760660T patent/PT1526839E/pt unknown
- 2003-06-20 MX MXPA04012852A patent/MXPA04012852A/es active IP Right Grant
- 2003-06-20 PL PL374388A patent/PL206599B1/pl not_active IP Right Cessation
- 2003-06-20 AT AT03760660T patent/ATE356612T1/de not_active IP Right Cessation
- 2003-06-20 EP EP03760660A patent/EP1526839B1/en not_active Expired - Lifetime
- 2003-06-20 IL IL16560103A patent/IL165601A0/xx not_active IP Right Cessation
- 2003-06-20 RU RU2004138554/15A patent/RU2323003C2/ru not_active IP Right Cessation
- 2003-06-20 WO PCT/EP2003/006496 patent/WO2004000273A1/en not_active Ceased
- 2003-06-20 ES ES03760660T patent/ES2285182T3/es not_active Expired - Lifetime
- 2003-06-20 DK DK03760660T patent/DK1526839T3/da active
- 2003-06-20 HK HK06100214.4A patent/HK1080364B/zh not_active IP Right Cessation
- 2003-06-20 KR KR1020047021307A patent/KR20060076136A/ko not_active Ceased
- 2003-06-20 JP JP2004514802A patent/JP2005530835A/ja active Pending
- 2003-06-20 SI SI200330822T patent/SI1526839T1/sl unknown
- 2003-06-20 US US10/515,621 patent/US20060171969A1/en not_active Abandoned
-
2004
- 2004-12-14 ZA ZA200410109A patent/ZA200410109B/xx unknown
-
2005
- 2005-01-21 NO NO20050347A patent/NO20050347L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004000273A1 (en) | 2003-12-31 |
| HK1080364A1 (en) | 2006-04-28 |
| MXPA04012852A (es) | 2005-06-08 |
| RU2323003C2 (ru) | 2008-04-27 |
| EP1526839B1 (en) | 2007-03-14 |
| JP2005530835A (ja) | 2005-10-13 |
| ITMI20021392A1 (it) | 2003-12-29 |
| KR20060076136A (ko) | 2006-07-04 |
| PL206599B1 (pl) | 2010-08-31 |
| SI1526839T1 (sl) | 2007-08-31 |
| NZ537204A (en) | 2006-07-28 |
| EP1526839A1 (en) | 2005-05-04 |
| PL374388A1 (en) | 2005-10-17 |
| CN1665486A (zh) | 2005-09-07 |
| HK1080364B (zh) | 2008-02-01 |
| US20060171969A1 (en) | 2006-08-03 |
| NO20050347L (no) | 2005-01-21 |
| ITMI20021392A0 (it) | 2002-06-25 |
| AU2003246564B2 (en) | 2008-06-12 |
| IL165601A0 (en) | 2006-01-15 |
| CN1319518C (zh) | 2007-06-06 |
| PT1526839E (pt) | 2007-06-06 |
| RU2004138554A (ru) | 2005-08-27 |
| ES2285182T3 (es) | 2007-11-16 |
| CA2491152A1 (en) | 2003-12-31 |
| DE60312523D1 (de) | 2007-04-26 |
| AU2003246564A1 (en) | 2004-01-06 |
| DE60312523T2 (de) | 2008-01-10 |
| ZA200410109B (en) | 2005-09-02 |
| DK1526839T3 (da) | 2007-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE356612T1 (de) | Orale, pharmazeutische darreichungsformen von flüssigen medikamenten mitverbesserter bioverfügbarkeit | |
| NO2025027I1 (no) | Pharmaceutical mixture or association that includes as active ingredients: (1) ceftazidime or a salt thereof, and (2) avibactam or a pharmaceutically acceptable salt thereof - forlenget. | |
| SE0003449D0 (sv) | Anticancer compositions | |
| AR033423A1 (es) | Sales farmaceuticas constituidas de una sustancia activa farmaceutica y al menos un edulcorante, medicamentos que contienen estas sales y uso de estas sales para la preparacion de medicamentos | |
| EA200401019A1 (ru) | Дозированная лекарственная форма для перорального применения, содержащая ингибитор pde 4 в качестве действующего вещества и поливинилпирролидон в качестве вспомогательного вещества | |
| EA200501586A1 (ru) | Фармацевтические продукты | |
| BG66093B1 (bg) | Състави с контролирано освобождаване, съдържащи нимесулид | |
| CY1111698T1 (el) | Συνδυασμος που περιλαμβανει εναν ανταγωνιστη υποδοχεα ατ1 και εναν ενισχυτη εκκρισης ινσουλινης ή εναν ευαισθητοποιητη ινσουλινης | |
| CO5560580A2 (es) | Formulaciones de sucralosa para disumular sabores desagradables | |
| DE60005819D1 (de) | Geschmacksmaskierte orale pharmazeutische zusammensetzungen mit kontrollierter abgabe | |
| NO20062504L (no) | Sammensetninger og doseringsformer for forbedret absorpsjon | |
| ATE509616T1 (de) | Topische pharmazeutische und/oder cosmetische dosierungssysteme | |
| ATE292453T1 (de) | Antivirale arznei | |
| MA29744B1 (fr) | Formulations posologiques solides de medicaments presentant une adsorption buccale amelioree | |
| EE200200522A (et) | Toimeainega konjugeerunud ensüüm-lõhustuv peptiid, seda sisaldav farmatseutiline kompositsioon ningühendi kasutamine kasvajavastase ravimina | |
| DE50005529D1 (de) | Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac | |
| DE60004797D1 (de) | Arzneimittel mit verzögerter wirkstoffabgabe enthaltend isoquercetin und ascorbinsäure | |
| DE69923336D1 (de) | Oral anzuwendende buprenorphinhaltige arzneimittel | |
| DE60102590D1 (de) | Darreichungsformen zur behandlung von oralen mykosen | |
| ATE374600T1 (de) | Pharmazeutische formulierung enthaltend olanzapin | |
| EA200701409A1 (ru) | Новая композиция | |
| TR200301553A1 (tr) | İrbesartan etken maddesi içeren yeni oral farmasötik formülasyonlar | |
| DK1273301T3 (da) | Farmaceutiske præparater baseret på aktive bestanddele der kan anvendes til ulovlig administration | |
| SE0203817D0 (sv) | New composition | |
| SV2006002224A (es) | Composicion farmaceutica ref. bhco41368-sv |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1526839 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |